These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37150895)

  • 1. A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults.
    Mun JG; Wang D; Doerflein Fulk DL; Fakhary M; Gualco SJ; Grant RW; Mitmesser SH
    J Diet Suppl; 2024; 21(2):182-194. PubMed ID: 37150895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults.
    Gooneratne NS; Edwards AY; Zhou C; Cuellar N; Grandner MA; Barrett JS
    J Pineal Res; 2012 May; 52(4):437-45. PubMed ID: 22348451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized, Crossover, Pharmacokinetics Evaluation of a Novel Continuous Release and Absorption Melatonin Formulation.
    Seiden DJ; Shah SM
    Prim Care Companion CNS Disord; 2019 Aug; 21(4):. PubMed ID: 31381847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers.
    Darwish M; Hellriegel ET
    Clin Ther; 2011 Jun; 33(6):746-53. PubMed ID: 21704239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin Bioavailability After Oral Administration of a New Delayed-Release Form in Healthy Male Volunteers.
    Ait Abdellah S; Gal C; Guinobert I; Bardot V; Raverot V; Vitacca A; Blondeau C; Claustrat B
    Drugs R D; 2024 Sep; 24(3):415-423. PubMed ID: 39174857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C; Berggren L; Patel JB; Eriksson H
    Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of Oniria
    Román Martinez M; García Aguilar E; Martin Vílchez S; González García J; Luquero-Bueno S; Camargo-Mamani P; Mejia-Abril G; García-Castro L; de Miguel-Cáceres A; Saz-Leal P; Abad-Santos F; Nieto Magro C; Ochoa Mazarro D
    Drugs R D; 2022 Sep; 22(3):235-243. PubMed ID: 35918587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial.
    Yang L; Zhang L; Luo Z
    Drug Des Devel Ther; 2023; 17():2369-2381. PubMed ID: 37600497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of melatonin supplementation as an add-on treatment for infantile epileptic spasms syndrome: A randomized, placebo-controlled, double-blind trial.
    Sun Y; Chen J; Shi X; Li Z; Wan L; Yan H; Chen Y; Wang J; Wang J; Zou L; Reiter R; Zhang B; Yang G
    J Pineal Res; 2024 Jan; 76(1):e12922. PubMed ID: 37909654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon.
    Greenblatt DJ; Harmatz JS; Walsh JK; Luthringer R; Staner L; Otmani S; Nedelec JF; Francart C; Parent SJ; Staner C
    Biopharm Drug Dispos; 2011 Dec; 32(9):489-97. PubMed ID: 21935965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers.
    Ait Abdellah S; Raverot V; Gal C; Guinobert I; Bardot V; Blondeau C; Claustrat B
    Drugs R D; 2023 Sep; 23(3):257-265. PubMed ID: 37438493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults : a randomized, open-label, two-period crossover, single-centre study.
    Darwish M; Hellriegel ET; Xie F
    Clin Drug Investig; 2008; 28(12):793-801. PubMed ID: 18991473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers.
    Schiavi P; Jochemsen R; Guez D
    Fundam Clin Pharmacol; 2000; 14(2):139-46. PubMed ID: 10796061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.
    Hauser RA; Hsu A; Kell S; Espay AJ; Sethi K; Stacy M; Ondo W; O'Connell M; Gupta S;
    Lancet Neurol; 2013 Apr; 12(4):346-56. PubMed ID: 23485610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
    PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.